Emerging Infectious Diseases (Jun 2024)

Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States

  • Isabel Griffin,
  • Jessica King,
  • B. Casey Lyons,
  • Alyson L. Singleton,
  • Xidong Deng,
  • Beau B. Bruce,
  • Patricia M. Griffin

DOI
https://doi.org/10.3201/eid3006.231285
Journal volume & issue
Vol. 30, no. 6
pp. 1144 – 1153

Abstract

Read online

Few precise estimates of hospitalization and fatality rates from COVID-19 exist for naive populations, especially within demographic subgroups. We estimated rates among persons with SARS-CoV-2 infection in the United States during May 1–December 1, 2020, before vaccines became available. Both rates generally increased with age; fatality rates were highest for persons >85 years of age (24%) and lowest for children 1–14 years of age (0.01%). Age-adjusted case hospitalization rates were highest for African American or Black, not Hispanic persons (14%), and case-fatality rates were highest for Asian or Pacific Islander, not Hispanic persons (4.4%). Eighteen percent of hospitalized patients and 44.2% of those admitted to an intensive care unit died. Male patients had higher hospitalization (6.2% vs. 5.2%) and fatality rates (1.9% vs. 1.5%) than female patients. These findings highlight the importance of collecting surveillance data to devise appropriate control measures for persons in underserved racial/ethnic groups and older adults.

Keywords